Career history of Michael Charles A. Booth
Former positions of Michael Charles A. Booth
| Companies | Position | Start | End |
|---|---|---|---|
| INCYTE CORPORATION | Investor Relations Contact | 2014-04-30 | - |
| Corporate Officer/Principal | 2014-04-30 | 2021-02-28 | |
| Canaccord Adams Ltd. | Analyst-Equity | 2003-06-19 | 2007-08-08 |
| ALGETA ASA | Investor Relations Contact | 2011-10-16 | - |
| Trout International LLC | Corporate Officer/Principal | 2006-12-31 | - |
Training of Michael Charles A. Booth
| University of Oxford | Doctorate Degree |
| University of St. Andrews | Undergraduate Degree |
Statistics
International
| United Kingdom | 5 |
| United States | 2 |
| Norway | 2 |
Operational
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 2 |
| Analyst-Equity | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
| Canaccord Adams Ltd. | Finance |
| Trout International LLC | |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
